Safusidenib is an investigational new drug that is being evaluated by AnHeart Therapeutics and the Daiichi Sankyo Company for the treatment of IDH1-mutant glioma.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.